This appears to be a distinct phenotypic change to Alpers’ syndrome astrocytes, which may be a secondary consequence to impaired astrocytic mitochondrial function, and differs from SUDEP patient group astrocytes, which frequently demonstrated a loss of Kir4.1 protein expression. Here, KCNJ10 is linked to Alpers syndrome.